COMMUNIQUÉS West-GlobeNewswire

HC3 Named Exclusive U.S. Distributor of MICA Advance System for Rapid Legionella Detection
15/10/2025
Tallahassee, Florida, Oct. 15, 2025 (GLOBE NEWSWIRE) -- HC3 Health Care Consulting has officially been named the exclusive U.S. distributor and training provider for the MICA Advance Legionella system , a next- [...]
EssilorLuxottica acquiert RetinAI, accélérant dans les solutions transformatrices de santé de l’œil portées par l'IA et la data
15/10/2025
EssilorLuxottica acquiert RetinAI, accélérant dans les solutions transformatrices de santé de l’œil portées par l'IA et la data Paris, France (15 octobre 2025) – EssilorLuxottica annonce l'acquisition d'Ikerian AG, une [...]
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
15/10/2025
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions Paris, France (15 October 2025) – EssilorLuxottica announces the acquisition of Ikerian AG, a health technology [...]
OSE Immunotherapeutics publie ses résultats financiers du 1er semestre 2025
15/10/2025
OSE Immunotherapeutics publie ses résultats financiers du 1 er semestre 2025 Nantes, France, le 15 octobre 2025, 19 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , publie aujourd’hui ses résultats [...]
OSE Immunotherapeutics Reports First Half 2025 Financial Results
15/10/2025
OSE Immunotherapeutics Reports First Half 2025 Financial Results NANTES, France, October 15, 2025 – 7:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , today reported its consolidated financial [...]
Rezolute to Participate in Upcoming Investor Conferences
15/10/2025
REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
15/10/2025
DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report [...]
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
15/10/2025
OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) [...]
Step Pharma announces completion of €38 million Series C financing
15/10/2025
Financing will support the Company’s ongoing clinical development of its lead asset, dencatistat, across multiple indications Round led by new investor V-Bio Ventures, with participation from existing investors Pontifax [...]
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
15/10/2025
Seasoned clinician and R&D leader brings extensive experience in translational medicine, drug development, and infectious disease research WESTLAKE VILLAGE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Extendicare Announces October 2025 Dividend of C$0.042 per Share
15/10/2025
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of [...]
Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
15/10/2025
NMPA’s response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage drug [...]
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio
15/10/2025
Collaboration and license agreement will advance Boehringer’s expanding antibody-drug conjugate (ADC) portfolio with a new asset expected to enter first-in-human studies next year . New, potentially best-in-class ADC is [...]
Chiesi Announces FDA Acceptance of New Drug Application for its Triple Combination Inhaler for the Maintenance Treatment of Asthma
15/10/2025
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the availability of many treatments. 1 Chiesi’s single inhaler triple therapy ( [...]
Sienna Announces October Dividend
15/10/2025
MARKHAM, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
15/10/2025
BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX) (the “Company”), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced [...]
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
15/10/2025
PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, will release third quarter 2025 financial results on Thursday, [...]
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
15/10/2025
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value JERSEY CITY, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq [...]
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
15/10/2025
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage to ~35% of European Union population with ~300,000 [...]

Pages